An exciting new treatment for lengthening and thickening eyelashes has just been approved by the FDA. This medication, marketed as Latisse, was initially used as eye drops for glaucoma. Patients who were using the eyedrops began developing longer, thicker and darker eyelashes. After the lengthy process of clinical trials, the FDA approved Latisse to be applied to the skin around the eyelashes for aesthetic purposes. Latisse is manufactured by Allergan, the make of Botox Cosmetic, and is available with a doctor's prescription.
Feb 13 2009